...
首页> 外文期刊>Renal failure. >Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients
【24h】

Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients

机译:基于体重的万古霉素治疗住院血液透析患者的评估

获取原文
获取原文并翻译 | 示例

摘要

Background: Current vancomycin dosing guidelines recommend targeting trough concentrations of 15-20mg/L in complicated infections to avoid treatment failure and resistance. How to accomplish this in the intermittent hemodialysis (IHD) population has not been adequately described. A weight-based vancomycin dosing protocol for IHD patients was developed to provide standardization of vancomycin dosing for this patient population. Prior to implementation of this protocol, clinical pharmacists used their individual judgment for dosing and monitoring.Objective: Compare achievement of goal (15-20mg/L) pre-IHD vancomycin levels between a group of patients dosed prior to implementation of this weight-based vancomycin dosing protocol and a group dosed after implementation.Methods: This retrospective study evaluated hospitalized IHD patients who received vancomycin and had an appropriate pre-IHD vancomycin level. Any patients with acute kidney injury or who required continuous renal replacement therapy or peritoneal dialysis were excluded.Results: A total of 145 vancomycin courses (94 pre-protocol and 51 post-protocol) were included in this study. The post-protocol group had an increased percentage of patients who achieved a pre-IHD vancomycin level of 15-20mg/L. We also found improvement in pre-IHD vancomycin levels attained in patients weighing less than 75kg and the need for additional study in patients weighing more than 105kg.Conclusion: Simplifying and standardizing vancomycin dosing for hospitalized IHD patients based on weight resulted in 37% of patients achieving goal pre-IHD vancomycin level of 15-20mg/L with zero patients having a pre-IHD vancomycin level <10mg/L.
机译:背景:目前的万古霉素剂量指南建议在复杂感染中将谷浓度设定为15-20mg / L,以避免治疗失败和耐药。在间歇性血液透析(IHD)人群中如何做到这一点尚未得到充分描述。开发了针对IHD患者的基于体重的万古霉素给药方案,以为该患者群体提供标准化的万古霉素给药方案。在实施该方案之前,临床药剂师根据其个人判断进行剂量和监测。目的:比较在实施基于体重的剂量之前,一组患者在IHD前万古霉素水平达到目标(15-20mg / L)的情况方法:这项回顾性研究评估了接受万古霉素且IHD前万古霉素水平适当的住院IHD患者。结果:本研究共纳入了145个万古霉素疗程(方案前为94个方案,方案后为51个方案),共排除了急性肾损伤或需要连续性肾脏替代治疗或腹膜透析的患者。协议后组达到IHD前万古霉素水平15-20mg / L的患者百分比增加。我们还发现体重小于75kg的患者可达到IHD前万古霉素水平的改善,体重大于105kg的患者需要进一步研究。结论:根据体重简化和标准化住院IHD患者的万古霉素剂量占患者总数的37% IHD前万古霉素水平<10mg / L的患者为零,实现IHD前万古霉素水平达到15-20mg / L的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号